Overview

Zmax Compared to Augmentin in Sinusitis

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
This study will enroll patients with Bacterial Sinusitis who will be treated with either Zmax (Azithromycin Extended Release) or Augmentin (Amoxicillin/Clavulanate). The purpose of the study is to compare early resolution of symptoms between the two treatments. Patients will report resolution of their sinusitis symptoms through a daily questionnaire. There will be two follow-up telephone interviews on days 12 and 28 to evaluate quality of life, satisfaction with therapy, and use of healthcare services.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Azithromycin
Clavulanic Acid
Clavulanic Acids